Advanced Genetic Technology

in the Service of People

EN Banner ESPA
Pacifi

Pacifi NIPT is a prenatal screening option to detect fetal chromosomal abnormalities more accurately than conventional biochemical testing and is available to all pregnant women.

KARYO performs the control with the certification of illumina, being the first NIPT system installation in Greece.

NGS Panels
KARYO OnTarget
KARYO Xplorer
KARYO Solution
KARYO HRD SOLID
KARYO TRAIL
KARYO Agendia
The private diagnostic laboratory KARYO provides advanced technology analyzes of genetic material to health professionals, since its establishment in 2008.

Who we are

The aim of the laboratory is the continuous development and provision of new diagnostic services based on its well-trained staff

Why to choose us

Accredited by ESYD clinical laboratory with long-term participation in international quality control programs and state-of-the-art equipment

Visit us

Find out about the communication methods and the location that serves you

Do you need clarification for your genetic tests?

Printed Information Material

Select to download the form you are interested in

Our people

Meet us through our CVs.

Tests

The analyzes we perform cover a wide range of modern diagnostic tests

Cytogenetics

Microbiological

Molecular Biology

See all our available Tests

Technological Equipment

The effort is continuous to have the most modern technological equipment in our laboratories.

Recent news

Find out about developments in Cytogenetics and Molecular Genetics as well as our new diagnostic tests

Scientific publication on SARS-CoV-2 virus detection methods by the KARYO team

On December 2019, a new coronavirus disease (COVID-19) emerged in China and spread worldwide, causing acute severe respiratory syndrome. Due to the increased transmission rate of the virus, it became of great importance the early diagnosis of the disease. The coronavirus pandemic led to the development of numerous tests in order to mass screening population for active viral load and for the identification of antibodies for epidemiological purposes. This review summarizes the different diagnostic tests available to the clinicians for the diagnosis and follow up of the SARS COV-2 infections.